Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
BackgroundEnuresis refers to urinary incontinence during sleep in children over 5 years of age. The pathogenesis of enuresis is complex. It is related to low functional bladder capacity, nocturnal bladder overactivity, and high arousal threshold, and it is also related to the immaturity of the central nervous system. Also, it was related to nocturnal polyuria and decreased nocturnal urine osmolality. There are many clinical observations that link nocturnal enuresis with developmental delay in language and physical growth. Vitamin D is important for the critical biological actions involving neural function and development. It is involved in the regulation of nerve growth factor synthesis. It also has a neuroprotective effect. It not only plays a vital role in skeletal growth but also has other critical biological actions in neural development and function. Furthermore, Vitamin D deficiency was linked to increased urinary output, which raised the question of whether Vitamin D levels are linked to nocturnal polyuria and decreased nocturnal urine osmolality. It was observed in the mice model study that Vitamin D is a negative regulator of the renin‐angiotensin system, and its deficiency leads to abnormal thirst and increased water intake by mice with Vitamin D deficiency and as much as twice urinary output than normal mice.Aim of the StudyTo evaluate the relationship between Vitamin D deficiency and nocturnal enuresis and to study the correlation between Vitamin D deficiency and urine osmolality, which is an indirect indicator of ADH deficiency.Patients and MethodsThis is a case‐control study that started in February 2020 and ended in August 2020 in our tertiary hospital. The study included 60 children with primary monosymptomatic nocturnal enuresis selected randomly and 60 healthy children as a control group. We compared Vitamin D levels, nocturnal polyuria, and nocturnal urine osmolality among both groups.ResultsIn our study, there was a statistically significant difference between both groups regarding serum Vitamin D values. The results of the serum Vitamin D level showed that 63.3% of cases with nocturnal enuresis had low Vitamin D levels with a mean range (18.8 ± 7.1) compared with 41.7% in the control group with a higher mean range (23.7 ± 9.6), and a p value of 0.002.ConclusionOur study indicates that there is a significant relationship between primary monosymptomatic nocturnal enuresis and serum Vitamin D deficiency in children. We also proved that Vitamin D level is correlated positively with nocturnal urine osmolality.Trial RegistrationClinical trials registration number: NCT06243042.
BackgroundEnuresis refers to urinary incontinence during sleep in children over 5 years of age. The pathogenesis of enuresis is complex. It is related to low functional bladder capacity, nocturnal bladder overactivity, and high arousal threshold, and it is also related to the immaturity of the central nervous system. Also, it was related to nocturnal polyuria and decreased nocturnal urine osmolality. There are many clinical observations that link nocturnal enuresis with developmental delay in language and physical growth. Vitamin D is important for the critical biological actions involving neural function and development. It is involved in the regulation of nerve growth factor synthesis. It also has a neuroprotective effect. It not only plays a vital role in skeletal growth but also has other critical biological actions in neural development and function. Furthermore, Vitamin D deficiency was linked to increased urinary output, which raised the question of whether Vitamin D levels are linked to nocturnal polyuria and decreased nocturnal urine osmolality. It was observed in the mice model study that Vitamin D is a negative regulator of the renin‐angiotensin system, and its deficiency leads to abnormal thirst and increased water intake by mice with Vitamin D deficiency and as much as twice urinary output than normal mice.Aim of the StudyTo evaluate the relationship between Vitamin D deficiency and nocturnal enuresis and to study the correlation between Vitamin D deficiency and urine osmolality, which is an indirect indicator of ADH deficiency.Patients and MethodsThis is a case‐control study that started in February 2020 and ended in August 2020 in our tertiary hospital. The study included 60 children with primary monosymptomatic nocturnal enuresis selected randomly and 60 healthy children as a control group. We compared Vitamin D levels, nocturnal polyuria, and nocturnal urine osmolality among both groups.ResultsIn our study, there was a statistically significant difference between both groups regarding serum Vitamin D values. The results of the serum Vitamin D level showed that 63.3% of cases with nocturnal enuresis had low Vitamin D levels with a mean range (18.8 ± 7.1) compared with 41.7% in the control group with a higher mean range (23.7 ± 9.6), and a p value of 0.002.ConclusionOur study indicates that there is a significant relationship between primary monosymptomatic nocturnal enuresis and serum Vitamin D deficiency in children. We also proved that Vitamin D level is correlated positively with nocturnal urine osmolality.Trial RegistrationClinical trials registration number: NCT06243042.
Purpose The aim of the present systematic review was to corroborate existing evidence on how serum25(OH)D levels affect obstructive sleep apnea syndrome (OSAS) severity in the absence of comorbidities. Methods From inception to May 2024, PubMed, Scopus, and Embase electronic databases were systematically screened to identify randomized controlled trials (RCTs), quasi-RCTs, prospective, and retrospective studies. A strict search protocol was applied following the application of PROSPERO, under the registration number CRD42023468744. The formulated question based on PICO process was: “how do serum25(OH)D levels affect the severity of OSAS or result in enhanced sleep function?”. Collected results were finally reviewed for meta-analysis and quality assessment according to the ROBINS-I tool. Results Data from 24 studies were pooled and divided into 15 case-control studies and 9 cross-sectional studies. All studies involved a total of 2640 OSAS subjects and 933 healthy subjects. All studies underwent qualitative analysis whereas only 20 were collected for meta-analysis. Mild OSAS showed 25(OH)D levels non-statistically significant ( P = 0.12) than the healthy patients whereas moderate OSAS ( P = 0.004) and severe OSAS ( P < 0.001) differed significantly from control groups. Meta-regression suggested that OSAS severity correlated inversely to the deficiency of 25(OH)D serum levels. Qualitative assessment and Egger’s test revealed an elevated risk of bias but low presence of publication bias, respectively. Conclusion Serum levels of 25(OH)D were observed to be inversely proportional to OSAS severity in patients without coexisting morbidities. 25(OH)D levels in mild OSAS patients were not significantly different from non-OSAS patients, suggesting vitamin supplementation to improve potential sleep disorders.
Background: Although there is evidence linking vitamin D to many neurochemical processes involved in sleep, the association between the obstructive sleep apnea and vitamin D, calcium and parathyroid hormone is still unknown, as clinical research have shown inconsistent findings. In this study, we aimed to examine the hypothesis that if there is any relationship between obstructive sleep apnea and serum vitamin D, calcium and parathyroid hormone levels in order to manage treatment. Methods: 56 patients (32 male, 24 female) admitted to the University of Health Sciences Adana City Training and Research Hospital otorhinolaryngology clinic between January 1st, 2022 and January 1st 2023 without any acute and chronic disease were included in the study. The range of participants was 18-70. In this study we examined the serum vitamin D, calcium and parathyroid hormone levels of 32 obstructive sleep apnea patients and compared their serum vitamin D, calcium and parathyroid hormone levels with the serum vitamin D, calcium and parathyroid hormone levels of 24 normal patients in the control group. Results: When the serum vitamin D, calcium and parathyroid hormone levels of obstructive sleep apnea patients and serum vitamin D, calcium and parathyroid hormone levels of normal patients were compared we did not find a statistically significant difference which may be due to our patient density. Conclusion: Vitamin D, calcium and parathyroid hormone levels are not likely related to the presence or absence of obstructive sleep apnea. More intervention studies are needed to better clarify the relation between the obstructive sleep apnea and vitamin D, calcium and parathyroid hormone.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.